Abutment Macro Design and Peri-implant Tissues

Sponsor
Nova Southeastern University (Other)
Overall Status
Completed
CT.gov ID
NCT02546713
Collaborator
Dentsply Sirona Implants (Industry)
28
1
2
72
0.4

Study Details

Study Description

Brief Summary

The aim of this study is to evaluate the effect of abutment macro-design on soft and hard tissue responses. This trial is designed as a randomized controlled clinical study in which two groups of fourteen partially edentulous patients will have as part of their treatment one implant placed in the maxillary premolar region.

Condition or Disease Intervention/Treatment Phase
  • Other: Abutment with concave subcritical contour
  • Other: Abutment with convex subcritical contour
N/A

Detailed Description

Implant placement and abutment design will be planned with a computer software for guided implant treatment (SIMPLANT). The surgical implant placement will be performed under manufacturer's protocol by placing the implant platform 1mm below the buccal aspect of the osteotomy (Koutouzis et al 2013). Virtually designed, permanent CAD-CAM fabricated abutments (ATLANTIS, DENTSPLY) with different configuration of the subcritical contour (emergence shape) will be connected to the implants and temporary crowns will be delivered.

Implants of the Group 1 will have permanent abutments with a concave configuration of the subcritical contour (emergence shape).

Implants of the Group 2 will have permanent abutments with a convex configuration of the subcritical contour (emergence shape).

The patients will be restored with single crowns 3 months following implant installation.

A randomization protocol will be produced from a computer-generated list for the distribution of subjects in the two treatment groups.

Study Design

Study Type:
Interventional
Actual Enrollment :
28 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
The Influence of Abutment Macro-design on Peri-implant Tissue Dimensions for Guided Placed and Restored Implants
Actual Study Start Date :
Dec 1, 2015
Actual Primary Completion Date :
Dec 1, 2020
Actual Study Completion Date :
Nov 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Other: Group 1

Abutments with a concave configuration of the subcritical contour (emergence shape).

Other: Abutment with concave subcritical contour
Implants will be restored with abutments with concave configuration of the subcritical contour

Other: Group 2

Abutments with convex configuration of the subcritical contour (emergence shape)

Other: Abutment with convex subcritical contour
Implants will be restored with abutments with convex configuration of the subcritical contour

Outcome Measures

Primary Outcome Measures

  1. Peri-implant mucosa margin position change [Day 7-10 to the Day 360]

    The primary outcome variable will be change on peri-implant mucosa margin position.

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
General Inclusion criteria:
    • Age more than 21 years
  • Absence of relevant medical conditions

  • Availability for 12 month follow-up

Specific Inclusion criteria:
  • One missing tooth in the maxillary premolar region

  • Presence of two adjacent teeth at the implant site

  • Absence of periodontal disease

  • Healed osseous architecture enough to receive an implant with a diameter of at least 3.5 mm and a sufficient amount of bone for placing implants with a length of at least 9 mm

General Exclusion Criteria:
    • Pregnancy at the screening visit.
  • Smoking more than 10 cig/day

Specific Exclusion criteria:
  • Adjacent implants

  • Presence of periapical radiolucency at the adjacent teeth

  • Missing adjacent teeth

Contacts and Locations

Locations

Site City State Country Postal Code
1 Nova Southeastern University Fort Lauderdale Florida United States 33328

Sponsors and Collaborators

  • Nova Southeastern University
  • Dentsply Sirona Implants

Investigators

  • Principal Investigator: Theofilos Koutouzis, DDS, Nova Southeastern University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Theofilos Koutouzis, Associate Professor, Nova Southeastern University
ClinicalTrials.gov Identifier:
NCT02546713
Other Study ID Numbers:
  • I-AA-14-075
First Posted:
Sep 11, 2015
Last Update Posted:
Apr 13, 2022
Last Verified:
Apr 1, 2022
Keywords provided by Theofilos Koutouzis, Associate Professor, Nova Southeastern University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 13, 2022